Aravive Performance
| ARAVDelisted Stock | USD 1.49 0.21 12.35% |
The firm shows a Beta (market volatility) of -0.0558, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Aravive are expected to decrease at a much lower rate. During the bear market, Aravive is likely to outperform the market. Aravive right now shows a risk of 0.0%. Please confirm Aravive potential upside, and the relationship between the jensen alpha and rate of daily change , to decide if Aravive will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Aravive has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Aravive is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
| Begin Period Cash Flow | 30.3 M |
Aravive |
Aravive Relative Risk vs. Return Landscape
If you would invest 149.00 in Aravive on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Aravive or generate 0.0% return on investment over 90 days. Aravive is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Aravive, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Aravive Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aravive's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aravive, and traders can use it to determine the average amount a Aravive's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ARAV |
Based on monthly moving average Aravive is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aravive by adding Aravive to a well-diversified portfolio.
Aravive Fundamentals Growth
Aravive Stock prices reflect investors' perceptions of the future prospects and financial health of Aravive, and Aravive fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aravive Stock performance.
| Return On Equity | -4.76 | |||
| Return On Asset | -1.34 | |||
| Operating Margin | (3.23) % | |||
| Current Valuation | (3.16 M) | |||
| Shares Outstanding | 73.56 M | |||
| Price To Earning | 3.34 X | |||
| Price To Book | 1.73 X | |||
| Price To Sales | 0.42 X | |||
| Revenue | 6.99 M | |||
| EBITDA | (58.4 M) | |||
| Cash And Equivalents | 46.83 M | |||
| Cash Per Share | 1.53 X | |||
| Total Debt | 6.27 M | |||
| Debt To Equity | 0.17 % | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | (59.45 M) | |||
| Earnings Per Share | (0.76) X | |||
| Total Asset | 62.15 M | |||
| Retained Earnings | (616.13 M) | |||
| Current Asset | 60.74 M | |||
| Current Liabilities | 11.48 M | |||
About Aravive Performance
Evaluating Aravive's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Aravive has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Aravive has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Aravive, Inc. was incorporated in 2008 and is headquartered in Houston, Texas. Aravive operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 23 people.Things to note about Aravive performance evaluation
Checking the ongoing alerts about Aravive for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aravive help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aravive is not yet fully synchronised with the market data | |
| Aravive may become a speculative penny stock | |
| Aravive has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 6.99 M. Net Loss for the year was (39.85 M) with loss before overhead, payroll, taxes, and interest of (57.8 M). | |
| Aravive currently holds about 46.83 M in cash with (59.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.53, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 39.0% of the company shares are held by company insiders |
- Analyzing Aravive's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aravive's stock is overvalued or undervalued compared to its peers.
- Examining Aravive's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aravive's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aravive's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aravive's stock. These opinions can provide insight into Aravive's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in Aravive Stock
If you are still planning to invest in Aravive check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aravive's history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |